Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$123.89M
Total Bought:
$33.69M
Total Sold:
$67.34M
Net Transaction:
-$33.65M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc1,870,0001,241,032-628,968$37.38M$21.28M17.18%-$16.10M
Evolus, Inc.(EOLS)1,369,8211,264,651-105,170$22.19M$13.96M11.27%-$8.23M
TELA Bio, Inc.(TELA)1,110,0002,353,099+1,243,099$2.81M$7.11M5.74%+$4.30M
Lakefront Biotherapeutics NVADR(LKFT)478,659200,000-278,659$13.78M$5.50M4.44%-$8.28M
Zevra Therapeutics, Inc.(ZVRA)700,000597,700-102,300$4.86M$4.98M4.02%+$126.8K
Verastem, Inc.(VSTM)1,310,287870,000-440,287$3.92M$4.50M3.63%+$580.1K
Acadia Pharmaceuticals Inc196,895220,000+23,105$3.03M$4.04M3.26%+$1.01M
Optinose Inc0588,657+588,657$0$3.93M3.17%+$3.93M
Anika Therapeutics Inc189,308238,222+48,914$4.68M$3.92M3.17%-$754.8K
Indivior Plc270,000305,000+35,000$2.63M$3.79M3.06%+$1.16M
Establishment Labs Holdings Inc.(ESTA)75,00080,002+5,002$3.25M$3.69M2.98%+$440.4K
Inhibikase Therapeutics, Inc.(IKT)01,132,388+1,132,388$0$3.68M2.97%+$3.68M
UroGen Pharma Ltd.(URGN)280,345324,324+43,979$3.56M$3.45M2.79%-$106.3K
Xoma Corp195,096125,700-69,396$5.17M$3.30M2.67%-$1.86M
Day One Biopharmaceuticals I
COM
205,675235,000+29,325$2.87M$2.98M2.40%+$112.4K
Ironwood Pharmaceuticals, Inc.CL A(IRWD)1,000,000648,785-351,215$4.12M$2.87M2.32%-$1.25M
Scpharmaceuticals Inc778,874683,530-95,344$3.55M$2.42M1.95%-$1.13M
Surrozen, Inc.(SRZN)110,000137,200+27,200$1.32M$1.97M1.59%+$651.0K
Inovio Pharmaceuticals, Inc.(INO)01,050,000+1,050,000$0$1.92M1.55%+$1.92M
Enanta Pharmaceuticals, Inc.(ENTA)0331,900+331,900$0$1.91M1.54%+$1.91M
Myomo, Inc.(MYO)100,000274,426+174,426$401.0K$1.77M1.43%+$1.37M
CalciMedica, Inc.(CALC)0468,793+468,793$0$1.66M1.34%+$1.66M
Aclaris Therapeutics, Inc.(ACRS)2,458,873663,405-1,795,468$2.83M$1.65M1.33%-$1.18M
Profound Medical Corp.(PROF)0200,000+200,000$0$1.50M1.21%+$1.50M
Jazz Pharmaceuticals plcSHS USD(JAZZ)55,00010,000-45,000$6.13M$1.23M0.99%-$4.90M
Vir Biotechnology, Inc.(VIR)0164,106+164,106$0$1.20M0.97%+$1.20M
Milestone Pharmaceuticals Inc.(MIST)999,790500,000-499,790$1.52M$1.18M0.95%-$339.7K
ANI Pharmaceuticals, Inc.(ANIP)020,400+20,400$0$1.13M0.91%+$1.13M
Heron Therapeutics, Inc.(HRTX)0700,000+700,000$0$1.07M0.86%+$1.07M
Exagen Inc.(XGN)534,398251,049-283,349$1.65M$1.03M0.83%-$622.0K
2seventy Bio Inc100,000300,000+200,000$472.0K$882.0K0.71%+$410.0K
Iteos Therapeutics Inc30,000110,000+80,000$306.3K$844.8K0.68%+$538.5K
PMV Pharmaceuticals, Inc.(PMVP)0535,805+535,805$0$809.1K0.65%+$809.1K
Kezar Life Sciences Inc
COM NEW
0110,000+110,000$0$739.2K0.60%+$739.2K
Aytu Biopharma Inc500,958407,549-93,409$1.18M$692.8K0.56%-$484.4K
Adicet Bio Inc609,446700,000+90,554$877.6K$673.4K0.54%-$204.2K
Kiora Pharmaceuticals, Inc.(KPRX)202,400200,970-1,430$740.8K$663.2K0.54%-$77.6K
Xeris Biopharma Holdings Inc0182,317+182,317$0$618.1K0.50%+$618.1K
Aquestive Therapeutics Inc0160,000+160,000$0$569.6K0.46%+$569.6K
Aprea Therapeutics, Inc.(APRE)137,174149,221+12,047$377.2K$490.9K0.40%+$113.7K
Acelyrin Inc0132,870+132,870$0$417.2K0.34%+$417.2K
Coherus Oncology, Inc.(CHRS)0250,000+250,000$0$345.0K0.28%+$345.0K
PolyPid Ltd.(PYPD)138,504103,668-34,836$476.5K$315.2K0.25%-$161.3K
Hillevax Inc0132,347+132,347$0$274.0K0.22%+$274.0K
An2 Therapeutics Inc0196,732+196,732$0$271.5K0.22%+$271.5K
Vanda Pharmaceuticals Inc.(VNDA)025,000+25,000$0$119.8K0.10%+$119.8K
Elevation Oncology Inc0200,000+200,000$0$112.5K0.09%+$112.5K
ABIVAX Société AnonymeADS(ABVX)015,000+15,000$0$109.8K0.09%+$109.8K
Alimera Sciences Inc Cvr2,408,4692,408,4690$96.3K$107.1K0.09%+$10.8K
Allarity Therapeutics Inc067,289+67,289$0$78.7K0.06%+$78.7K
Revance Therapeutics Inc820,00023,264-796,736$4.26M$70.7K0.06%-$4.19M
Amarin Corporation Plc -AdrADR0114,257+114,257$0$55.4K0.04%+$55.4K
Arcutis Biotherapeutics, Inc.(ARQT)88,4570-88,457$822.6K$0—-$822.6K
Kezar Life Sciences Inc1,491,3050-1,491,305$1.15M$0—-$1.15M
Optinose Inc5,688,5900-5,688,590$3.81M$0—-$3.81M
Paragon 28 Inc114,7240-114,724$766.4K$0—-$766.4K
Rigel Pharmaceuticals, Inc.(RIGL)309,1000-309,100$5.00M$0—-$5.00M
Royalty Pharma plcCL A(RPRX)212,0000-212,000$6.00M$0—-$6.00M
Tenax Therapeutics, Inc.(TENX)50,0000-50,000$173.0K$0—-$173.0K
Viracta Therapeutics Inc500,0000-500,000$115.7K$0—-$115.7K
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q4 2024 | TickerTrail